Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$479.63 USD
-6.99 (-1.44%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $479.65 +0.02 (0.00%) 7:14 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$479.63 USD
-6.99 (-1.44%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $479.65 +0.02 (0.00%) 7:14 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Why Is Intuitive Surgical, Inc. (ISRG) Down 8.4% Since Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Analyst Reports for Amazon, Tesla & NextEra
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Amazon.com (AMZN), Tesla (TSLA), and NextEra Energy (NEE).
Here's Why You Should Retain Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System. However, rise in production costs is a woe.
The Zacks Analyst Blog Highlights: Deere, Cognex, Rockwell Automation, ABB and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Deere, Cognex, Rockwell Automation, ABB and Intuitive Surgical
5 Stocks to Watch as Automation Drives Demand for Robotics
by Kaustav Ghosh
Increased efficiency and precision has been driving demand for robotics across industries, making it wise to look at names like Deere & Co. (DE), Cognex (CGNX), ABB (ABB) and Intuitive Surgical (ISRG)
The Zacks Analyst Blog Highlights: Johnson & Johnson, Stryker, Boston Scientific Corp, Intuitive Surgical and Asensus Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Stryker, Boston Scientific Corp, Intuitive Surgical and Asensus Surgical
Innovation Drives Robotic-Assisted Surgery: 5 Stocks to Watch
by Sreoshi Bera
Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).
Here's How Much You'd Have If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Intuitive Surgical, Inc. (ISRG) Surges 9.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Intuitive Surgical (ISRG) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect strong segmental performance.
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 34.87% and 16.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Why You Should Hold AngioDynamics (ANGO) in Your Portfolio
by Zacks Equity Research
Investor optimism is high on AngioDynamics (ANGO) stock, courtesy of its solid prospects.
Cardinal Health (CAH), HHS Partner to Offer Pandemic Support
by Zacks Equity Research
The contract should help Cardinal Health (CAH) provide critical pandemic support in partnership with the U.S. government.
Thermo Fisher (TMO) to Expand in Pharma Service With PPD Buyout
by Zacks Equity Research
Thermo Fisher's (TMO) $17.4-billion acquisition deal will offer the company meaningful cost and revenue synergies.
STERIS (STE) Hits a New 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.
What's in Store for Intuitive Surgical's (ISRG) Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter earnings are likely to reflect solid performance at Instruments & Accessories segment.
If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Earnings Preview: Intuitive Surgical, Inc. (ISRG) Q1 Earnings Expected to Decline
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System. However, weakness at the Systems segment is a woe.
The Zacks Analyst Blog Highlights: Apple, Alibaba Group, AT&T, Intuitive Surgical and Zoetis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Alibaba Group, AT&T, Intuitive Surgical and Zoetis
Top Stock Reports for Apple, Alibaba & AT&T
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Alibaba Group Holding Limited (BABA) and AT&T Inc. (T).
3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
by Urmimala Biswas
Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Instruments industry. NTUS, IDXX and HOLX are well positioned to gain.
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic
Coronavirus Ups the Game for Robotic Surgery: 3 Stocks on Radar
by Sriparna Ghosal
Let's keep a watch on the potentially strong three MedTech stocks, namely SYK, ARAY and MDT with respect to robotic-assisted surgery that showed promises during the pandemic.